A groundbreaking study in Lithuania, LumoKaunas2023, has been launched to examine the effectiveness of antibacterial, light-activated therapy in treating severe periodontitis. Established in August 2023 in Kaunas, the study is investigating the regular use of the Lumoral device as an adjunct therapy for managing chronic stage III to IV periodontitis.
The study, led by Ingrida Pacauskiené, aims to recruit 60 participants, with 38 already enrolled.
The Lumoral device, developed by Finnish scientists, combines a specialised mouthwash with antibacterial dual-light therapy. Building on findings from the earlier HOPE-CP study, which demonstrated its efficacy in managing early-stage periodontitis, LumoKaunas2023 focuses on more advanced cases requiring intensive treatment.
Register now to continue reading
Thank you for visiting Dental Nursing and reading some of our resources. To read more, please register today. You’ll enjoy the following great benefits:
What's included
-
Up to 2 free articles per month
-
New content available
Already have an account? Sign in here